Radiotherapy has played an important role in treatment of tumor patientssince it appeared about 80 years ago, and has been an indispensable part of the management of about50% of tumors (especially 60% - 70% of maligna...Radiotherapy has played an important role in treatment of tumor patientssince it appeared about 80 years ago, and has been an indispensable part of the management of about50% of tumors (especially 60% - 70% of malignant tumors). Currently, radiotherapy is used in simpleand palliative therapy, adjuvant therapy after or before surgery, simultaneous radio-chemotherapy,combined BRM (biological response modifier) therapy, ets. Radiosensitizing agents enhance theradiation effects on tumor cells so as to have better responses in radiotherapy. Tumor intrinsicradiosensitivity is affected by the hy-poxic level in solid tumor, the ability of the cells torepair the radiation-induced DNA damage, the number of cells which have a clonogenic capability toreestablish uncontrolled cell growth, the amount of dividing cells, and the distribution of cellsthroughout the cell cycle. Consequently , it is necessary and useful to add one or moreradiosensitizing agents in radiotherapy to increase the radio-sensitivity of tumor cells.展开更多
Actually, radiation alone is not enough to kill tumor cells efficientlybecause of the radioresistance of tumor cells. It is well known that tumors from the samehistolog-ical origin and of the same development stage ar...Actually, radiation alone is not enough to kill tumor cells efficientlybecause of the radioresistance of tumor cells. It is well known that tumors from the samehistolog-ical origin and of the same development stage are extremely heterogeneous in theirsensitivity to radiotherapy. One of the most resistant factors to radiation is that tumor cells arecommonly hypoxic. The study on radiosensitizing agents is one of the most interesting issues intumor radiotherapeutics. These radiosensitizing agents can be classified into three main categories:natural products, synthesized chemicals and gene therapeutic agents according to their origins andtherapeutic techniques. Many radiosensitizing agents have some side-effects when they are active;so, it is important and significant to do our best to find more radiosensitizing agents with higherefficiency and lower side-effects. On the other hand, the tumor cells are easy to become resistantto older radiosensitizing agents; hence, it is urgent to develop newer radiosensitizing agents forclinics. Natural products come from plants, animals and other living beings. When serving asradiosensitizing agents in tumor radiotherapy, they are more attractive and predominant than generaldrugs. The reasons include a great resource ( especially in China) , multifunctional regulation,higher effectiveness and safer clinical effects.展开更多
文摘Radiotherapy has played an important role in treatment of tumor patientssince it appeared about 80 years ago, and has been an indispensable part of the management of about50% of tumors (especially 60% - 70% of malignant tumors). Currently, radiotherapy is used in simpleand palliative therapy, adjuvant therapy after or before surgery, simultaneous radio-chemotherapy,combined BRM (biological response modifier) therapy, ets. Radiosensitizing agents enhance theradiation effects on tumor cells so as to have better responses in radiotherapy. Tumor intrinsicradiosensitivity is affected by the hy-poxic level in solid tumor, the ability of the cells torepair the radiation-induced DNA damage, the number of cells which have a clonogenic capability toreestablish uncontrolled cell growth, the amount of dividing cells, and the distribution of cellsthroughout the cell cycle. Consequently , it is necessary and useful to add one or moreradiosensitizing agents in radiotherapy to increase the radio-sensitivity of tumor cells.
文摘Actually, radiation alone is not enough to kill tumor cells efficientlybecause of the radioresistance of tumor cells. It is well known that tumors from the samehistolog-ical origin and of the same development stage are extremely heterogeneous in theirsensitivity to radiotherapy. One of the most resistant factors to radiation is that tumor cells arecommonly hypoxic. The study on radiosensitizing agents is one of the most interesting issues intumor radiotherapeutics. These radiosensitizing agents can be classified into three main categories:natural products, synthesized chemicals and gene therapeutic agents according to their origins andtherapeutic techniques. Many radiosensitizing agents have some side-effects when they are active;so, it is important and significant to do our best to find more radiosensitizing agents with higherefficiency and lower side-effects. On the other hand, the tumor cells are easy to become resistantto older radiosensitizing agents; hence, it is urgent to develop newer radiosensitizing agents forclinics. Natural products come from plants, animals and other living beings. When serving asradiosensitizing agents in tumor radiotherapy, they are more attractive and predominant than generaldrugs. The reasons include a great resource ( especially in China) , multifunctional regulation,higher effectiveness and safer clinical effects.
